Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · December 07, 2022

Clinical Outcomes in Patients After Ranibizumab Reinjection for the Reactivation of Retinopathy of Prematurity

Eye (London, England)


Additional Info

Eye (London, England)
Clinical outcome following reinjection of Ranibizumab for reactivation of retinopathy of prematurity
Eye (Lond) 2022 Nov 01;36(11)2137-2143, RM Bassiouny, WM Gaafar, A El Nokrashy, AG Abdelhameed, EA Attallah, AG Elgharieb, MR Bassiouny

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading